Stockchase Opinions

Brett Girard, CPA, CA, CFA Novozymes NZYMB-CPH PAST TOP PICK Apr 25, 2023

(A Top Pick Mar 25/22, Down 14%)

They make things such as the additive that goes into cold-water detergent. Does 2.5 billion Euros in revenues plus 1 billion more with a Swiss company. But the market doesn't like this acquisition, because it diluted shares He liked the deal, because Novozymes did the buy without adding debt. Combined companies enlarges free cash flow and market share, which will be 50%. Will grow in time.

N/A

Stock price when the opinion was issued

chemicals
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

TOP PICK
Global leader in enzymes, 48% market share. Dividend has grown by 16% since 2000. Stock's been trading sideways, so with share buybacks investors get a bigger piece of the pie. 34% of sales come from EM. Enzymes are low in cost, but have a big impact on the outcome. Yield is 1.27%.
TOP PICK
Danish biotech company. Company that enabling consumers to transition to greener options. Less dependent on traditional energy sources. Would recommend buying.